ArticleMolecular cancer research : MCR2021

A New Pipeline to Predict and Confirm Tumor Neoantigens Predict Better Response to Immune Checkpoint Blockade.

Yelena Lazdun et al.PubMed ↗Publisher ↗

No numbers read from the abstract.